A citation-based method for searching scientific literature

Birgit Knoechel, Justine E Roderick, Kaylyn E Williamson, Jiang Zhu, Jens G Lohr, Matthew J Cotton, Shawn M Gillespie, Daniel Fernandez, Manching Ku, Hongfang Wang, Federica Piccioni, Serena J Silver, Mohit Jain, Daniel Pearson, Michael J Kluk, Christopher J Ott, Leonard D Shultz, Michael A Brehm, Dale L Greiner, Alejandro Gutierrez, Kimberly Stegmaier, Andrew L Kung, David E Root, James E Bradner, Jon C Aster, Michelle A Kelliher, Bradley E Bernstein. Nat Genet 2014
Times Cited: 237



Denes Hnisz, Brian J Abraham, Tong Ihn Lee, Ashley Lau, Violaine Saint-André, Alla A Sigova, Heather A Hoke, Richard A Young. Cell 2013
Times Cited: 1882




List of shared articles



Times cited

Enhancer rewiring in tumors: an opportunity for therapeutic intervention.
Laia Richart, François-Clément Bidard, Raphaël Margueron. Oncogene 2021
4

General mechanism of JQ1 in inhibiting various types of cancer.
Guojuan Jiang, Wanglong Deng, Yang Liu, Chengde Wang. Mol Med Rep 2020
12

Enhancers and MYC interplay in hematopoiesis.
Leonidas Benetatos, Agapi Benetatou, George Vartholomatos. J Mol Med (Berl) 2020
4

Noncoding Variants Connect Enhancer Dysregulation with Nuclear Receptor Signaling in Hematopoietic Malignancies.
Kailong Li, Yuannyu Zhang, Xin Liu, Yuxuan Liu, Zhimin Gu, Hui Cao, Kathryn E Dickerson, Mingyi Chen, Weina Chen, Zhen Shao,[...]. Cancer Discov 2020
11

Super-Enhancer Redistribution as a Mechanism of Broad Gene Dysregulation in Repeatedly Drug-Treated Cancer Cells.
Qi Ma, Feng Yang, Carlos Mackintosh, Ranveer Singh Jayani, Soohwan Oh, Chunyu Jin, Sreejith Janardhanan Nair, Daria Merkurjev, Wubin Ma, Stephanie Allen,[...]. Cell Rep 2020
17

Self-Reporting Transposons Enable Simultaneous Readout of Gene Expression and Transcription Factor Binding in Single Cells.
Arnav Moudgil, Michael N Wilkinson, Xuhua Chen, June He, Alexander J Cammack, Michael J Vasek, Tomás Lagunas, Zongtai Qi, Matthew A Lalli, Chuner Guo,[...]. Cell 2020
15

Super-enhancers in cancer.
Palaniraja Thandapani. Pharmacol Ther 2019
34

Perturbing Enhancer Activity in Cancer Therapy.
Feda H Hamdan, Steven A Johnsen. Cancers (Basel) 2019
10

BCL2 Amplicon Loss and Transcriptional Remodeling Drives ABT-199 Resistance in B Cell Lymphoma Models.
Xiaohong Zhao, Yuan Ren, Matthew Lawlor, Bijal D Shah, Paul M C Park, Tint Lwin, Xuefeng Wang, Kenian Liu, Michelle Wang, Jing Gao,[...]. Cancer Cell 2019
35